Isochoric supercooled preservation and revival of human cardiac microtissues.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
22 09 2021
Historique:
received: 13 04 2021
accepted: 09 09 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

Low-temperature biopreservation and 3D tissue engineering present two differing routes towards eventual on-demand access to transplantable biologics, but recent advances in both fields present critical new opportunities for crossover between them. In this work, we demonstrate sub-zero centigrade preservation and revival of autonomously beating three-dimensional human induced pluripotent stem cell (hiPSC)-derived cardiac microtissues via isochoric supercooling, without the use of chemical cryoprotectants. We show that these tissues can cease autonomous beating during preservation and resume it after warming, that the supercooling process does not affect sarcomere structural integrity, and that the tissues maintain responsiveness to drug exposure following revival. Our work suggests both that functional three dimensional (3D) engineered tissues may provide an excellent high-content, low-risk testbed to study complex tissue biopreservation in a genetically human context, and that isochoric supercooling may provide a robust method for preserving and reviving engineered tissues themselves.

Identifiants

pubmed: 34552201
doi: 10.1038/s42003-021-02650-9
pii: 10.1038/s42003-021-02650-9
pmc: PMC8458396
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1118

Informations de copyright

© 2021. The Author(s).

Références

Adv Sci (Weinh). 2020 Oct 12;7(22):2002030
pubmed: 33240763
Nat Biotechnol. 2019 Oct;37(10):1131-1136
pubmed: 31501557
Curr Opin Organ Transplant. 2018 Jun;23(3):336-346
pubmed: 29683801
Sci Rep. 2015 Mar 09;5:8883
pubmed: 25748532
Cryobiology. 1986 Feb;23(1):1-13
pubmed: 3956226
J Am Heart Assoc. 2016 Jun 17;5(6):
pubmed: 27317349
Trends Pharmacol Sci. 2021 Feb;42(2):119-133
pubmed: 33341248
Transfus Med Hemother. 2019 Jun;46(3):197-215
pubmed: 31244588
Nat Med. 2014 Jul;20(7):790-3
pubmed: 24973919
Front Pharmacol. 2020 Feb 12;10:1648
pubmed: 32116671
Nat Biotechnol. 2017 Jun 7;35(6):530-542
pubmed: 28591112
Sci Rep. 2018 Dec 4;8(1):17626
pubmed: 30514966
Tissue Eng Part C Methods. 2015 May;21(5):467-79
pubmed: 25333967
Nat Biotechnol. 2019 Oct;37(10):1127-1128
pubmed: 31501562
J Cell Physiol. 2019 Jun;234(6):8352-8380
pubmed: 30443904
Heart Fail Rev. 2003 Jul;8(3):277-84
pubmed: 12878837
Curr Opin Organ Transplant. 2017 Jun;22(3):281-286
pubmed: 28266941
Clin Transl Sci. 2021 May;14(3):1155-1165
pubmed: 33786981
Biomed Eng Online. 2020 Feb 12;19(1):9
pubmed: 32050989
Nat Commun. 2018 Aug 10;9(1):3201
pubmed: 30097570
Circulation. 2001 Apr 17;103(15):2004-13
pubmed: 11306531

Auteurs

Matthew J Powell-Palm (MJ)

Department of Mechanical Engineering, University of California at Berkeley, Berkeley, CA, 94720, USA. mpowellp@berkeley.edu.

Verena Charwat (V)

Department of Bioengineering, University of California at Berkeley, Berkeley, CA, 94720, USA.

Berenice Charrez (B)

Department of Bioengineering, University of California at Berkeley, Berkeley, CA, 94720, USA.

Brian Siemons (B)

Department of Bioengineering, University of California at Berkeley, Berkeley, CA, 94720, USA.

Kevin E Healy (KE)

Department of Bioengineering, University of California at Berkeley, Berkeley, CA, 94720, USA. kehealy@berkeley.edu.
Department of Materials Science and Engineering, University of California at Berkeley, Berkeley, CA, 94720, USA. kehealy@berkeley.edu.

Boris Rubinsky (B)

Department of Mechanical Engineering, University of California at Berkeley, Berkeley, CA, 94720, USA. rubinsky@berkeley.edu.
Department of Bioengineering, University of California at Berkeley, Berkeley, CA, 94720, USA. rubinsky@berkeley.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH